Shots: Takeda to receive ~$660M for divesting its 20 select prescription pharmaceutical and OTC products traded in Russia, Georgia, and several countries within the Commonwealth of Independent States. STADA to […]readmore
Tags : $660M
Shots: Smith & Nephew acquires Osiris Therapeutics, in all stock transaction for $19/share at a premium of 37% making the total deal value $660M. The transaction is expected to close […]readmore